1-3 of 3
Gonzalo Lopez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Immune Dynamics and Treatment Outcome in Patients (pts) with Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) Treated with the Novel Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Agent CC-99282

Soraya Carrancio, Wen-Chi Chou, Alberto Risueño, Carla Guarinos, Gonzalo Lopez, Jean-Marie Michot, Loretta J. Nastoupil, Julio Chavez, Cecilia Carpio, Silvia Ferrari, Tatyana A. Feldman, Daniel Morillo Giles, Antonio Pinto, Danielle Greenawalt, Daniel W. Pierce, Michael Pourdehnad
Journal: Blood
Blood (2022) 140 (Supplement 1): 6455–6457.
https://doi.org/10.1182/blood-2022-159585
Published: 2022
Journal Articles

Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia

Shao-Qing Kuang, Hao Bai, Zhi-Hong Fang, Gonzalo Lopez, Hui Yang, Weigang Tong, Zack Z. Wang, Guillermo Garcia-Manero
Journal: Blood
Blood (2010) 115 (12): 2412–2419.
https://doi.org/10.1182/blood-2009-05-222208
Published: 2010
Includes: Supplemental data
Journal Articles

Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.

Shao-qing Kuang, MD, PhD, Zhi-Hong Fang, PhD, Gonzalo Lopez, Weigang Tong, MD, PhD, Hui Yang, MD, PhD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2007) 110 (11): 2128.
https://doi.org/10.1182/blood.V110.11.2128.2128
Published: 2007